These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33661961)

  • 1. A convenient approach to synthesize substituted 5-Arylidene-3-m-tolyl thiazolidine-2, 4-diones by using morpholine as a catalyst and its theoretical study.
    Jahan K; Khan KR; Akhter K; Romman UKR; Halim E
    PLoS One; 2021; 16(3):e0247619. PubMed ID: 33661961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of thiazolidine-2,4-dione/biphenylcarbonitrile hybrid as dual PPAR α/γ modulator with antidiabetic effect: in vitro, in silico and in vivo approaches.
    Hidalgo-Figueroa S; Ramírez-Espinosa JJ; Estrada-Soto S; Almanza-Pérez JC; Román-Ramos R; Alarcón-Aguilar FJ; Hernández-Rosado JV; Moreno-Díaz H; Díaz-Coutiño D; Navarrete-Vázquez G
    Chem Biol Drug Des; 2013 Apr; 81(4):474-83. PubMed ID: 23289972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design and synthesis of some PPAR-γ agonists: Substituted benzylideneamino-benzylidene-thiazolidine-2,4-diones.
    Chhajed SS; Chaskar S; Kshirsagar SK; Haldar GM; Kar Mahapatra D
    Comput Biol Chem; 2017 Apr; 67():260-265. PubMed ID: 28193552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biological evaluation and molecular docking studies of novel 3,5-disubstituted 2,4-thiazolidinediones derivatives.
    Ranjan Srivastava A; Bhatia R; Chawla P
    Bioorg Chem; 2019 Aug; 89():102993. PubMed ID: 31129500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of novel thiazolidinediones as PPARγ/FFAR1 dual agonists.
    Darwish KM; Salama I; Mostafa S; Gomaa MS; Helal MA
    Eur J Med Chem; 2016 Feb; 109():157-72. PubMed ID: 26774923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, biological evaluation and molecular modeling studies of arylidene-thiazolidinediones with potential hypoglycemic and hypolipidemic activities.
    da Costa Leite LF; Veras Mourão RH; de Lima Mdo C; Galdino SL; Hernandes MZ; de Assis Rocha Neves F; Vidal S; Barbe J; da Rocha Pitta I
    Eur J Med Chem; 2007 Oct; 42(10):1263-71. PubMed ID: 17448573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and anti-inflammatory activity of new arylidene-thiazolidine-2,4-diones as PPARgamma ligands.
    Barros CD; Amato AA; de Oliveira TB; Iannini KB; Silva AL; Silva TG; Leite ES; Hernandes MZ; Alves de Lima Mdo C; Galdino SL; Neves Fde A; Pitta Ida R
    Bioorg Med Chem; 2010 Jun; 18(11):3805-11. PubMed ID: 20471839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis, and Biological Evaluation of Thiazolidine-2,4-dione Conjugates as PPAR-γ Agonists.
    Nazreen S; Alam MS; Hamid H; Shahar Yar M; Dhulap A; Alam P; Pasha MA; Bano S; Alam MM; Haider S; Kharbanda C; Ali Y; Pillai K
    Arch Pharm (Weinheim); 2015 Jun; 348(6):421-32. PubMed ID: 25900064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural characterization of impurities in pioglitazone.
    Kumar YR; Reddy AR; Eswaraiah S; Mukkanti K; Reddy MS; Suryanarayana MV
    Pharmazie; 2004 Nov; 59(11):836-9. PubMed ID: 15587582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, docking, in vitro and in vivo antidiabetic activity of pyrazole-based 2,4-thiazolidinedione derivatives as PPAR-γ modulators.
    Naim MJ; Alam O; Alam MJ; Shaquiquzzaman M; Alam MM; Naidu VGM
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700223. PubMed ID: 29400412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antihyperglycemic activity profiles of novel thiazolidinedione derivatives.
    Bhat BA; Ponnala S; Sahu DP; Tiwari P; Tripathi BK; Srivastava AK
    Bioorg Med Chem; 2004 Nov; 12(22):5857-64. PubMed ID: 15498661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures of PPARγ complexed with lobeglitazone and pioglitazone reveal key determinants for the recognition of antidiabetic drugs.
    Lee MA; Tan L; Yang H; Im YG; Im YJ
    Sci Rep; 2017 Dec; 7(1):16837. PubMed ID: 29203903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of polymeric thiazolidinediones and L-ascorbic acid towards the development of insulin-sensitizer.
    Lee SM; Jeon R
    Arch Pharm Res; 2005 Apr; 28(4):377-81. PubMed ID: 15918508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review on the development in the field of NIDDM based thiazolidinedione PPARγ agonists.
    Banerjee PS; Samanta S
    Mini Rev Med Chem; 2013 Apr; 13(5):706-12. PubMed ID: 22512587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazolidine-2,4-diones: progress towards multifarious applications.
    Jain VS; Vora DK; Ramaa CS
    Bioorg Med Chem; 2013 Apr; 21(7):1599-620. PubMed ID: 23419324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization and biological evaluation of some novel 2,4-thiazolidinediones as potential cytotoxic, antimicrobial and antihyperglycemic agents.
    Avupati VR; Yejella RP; Akula A; Guntuku GS; Doddi BR; Vutla VR; Anagani SR; Adimulam LS; Vyricharla AK
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6442-50. PubMed ID: 22981328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis and structural study of 5-arylidene thiazolidine-2,4-diones and 3-substituted-4-thio-imidazolidine-2-ones].
    Albuquerque JF; Azevedo LC; Galdino SL; Chantegrel J; Pitta IR; Luu-Duc C
    Ann Pharm Fr; 1995; 53(5):209-14. PubMed ID: 7503509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive review on the antidiabetic attributes of thiazolidine-4-ones: Synthetic strategies and structure-activity relationships.
    Pradhan T; Gupta O; Kumar V; Sristi ; Chawla G
    Arch Pharm (Weinheim); 2023 Feb; 356(2):e2200452. PubMed ID: 36378997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of thiazolidine-2,4-dione-pyrazole conjugates as antidiabetic, anti-inflammatory and antioxidant agents.
    Bansal G; Singh S; Monga V; Thanikachalam PV; Chawla P
    Bioorg Chem; 2019 Nov; 92():103271. PubMed ID: 31536952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concise perspectives on some synthetic thiazolidine-2,4-dione derivatives and their specific pharmacodynamic aspects.
    Vulichi SR; Kabra A; Kumar R; Suman K; Rao CV; Cruz-Martins N
    Life Sci; 2021 Apr; 271():119182. PubMed ID: 33577851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.